sufentanil has been researched along with indocyanine green in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Boer, F; Bovill, JG; Burm, AG; Mooren, RA | 1 |
| Boer, F; Bovill, JG; Burm, AG; Hak, A | 1 |
1 review(s) available for sufentanil and indocyanine green
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for sufentanil and indocyanine green
| Article | Year |
|---|---|
Effect of ventilation on first-pass pulmonary retention of alfentanil and sufentanil in patients undergoing coronary artery surgery.
Topics: Alfentanil; Anesthesia, General; Apnea; Coronary Artery Bypass; Hemodynamics; Humans; Indocyanine Green; Intermittent Positive-Pressure Ventilation; Lung; Positive-Pressure Respiration; Sufentanil | 1994 |
2 other study(ies) available for sufentanil and indocyanine green
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Uptake of sufentanil, alfentanil and morphine in the lungs of patients about to undergo coronary artery surgery.
Topics: Alfentanil; Coronary Artery Bypass; Fentanyl; Humans; Indocyanine Green; Lung; Morphine; Sufentanil; Time Factors | 1992 |